Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Pozycja w akcjach
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Cena akcji
$8.03
Kapitalizacja rynkowa
$6.31B
Zmiana (1 dzień)
1.07%
Zmiana (1 rok)
-8.04%
Kraj
CN
Handel Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Kategoria
Healthcare
Historia stopy dywidendy dla Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Stopa dywidendy (TTM) dla Shenzhen New Industries Biomedical Engineering Co., Ltd. (symbol akcji: 300832) na dzień 2024-12-31 wynosi: 1.41%
Średnia stopa dywidendy z ostatnich 5 lat: 1.40%
Średnia stopa dywidendy z ostatnich 5 lat: 1.40%
Historia stopy dywidendy dla Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832) od 2012 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 2.24% | -3.03% |
| 2025 | 2.31% | 63.83% |
| 2024 | 1.41% | 56.67% |
| 2023 | 0.90% | -25.00% |
| 2022 | 1.20% | 0.84% |
| 2021 | 1.19% | 4.39% |
| 2020 | 1.14% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | 0.60% | -45.95% |
| 2017 | 1.11% | 236.36% |
| 2016 | 0.33% | 26.92% |
| 2015 | 0.26% | 85.71% |
| 2014 | 0.14% | 100.00% |
| 2013 | 0.07% | 16.67% |
| 2012 | 0.06% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 2.51% |
US
|
|
| 3.02% |
IE
|
|
| 1.14% |
US
|
|
| 0.00% |
US
|
|
| 2.39% |
DE
|
